Literature DB >> 2107878

Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu----Lys). A novel apolipoprotein variant.

Y Takada1, J Sasaki, S Ogata, T Nakanishi, Y Ikehara, K Arakawa.   

Abstract

A novel genetic variant of apolipoprotein(apo) A-I Fukuoka, has been identified in a Japanese family. This variant has a relative charge of +2 compared to normal apolipoprotein A-I (A-I4), on the isoelectric focusing gels and the same molecular mass and immunologic characteristics as normal apolipoprotein A-I. This variant, transmitted as an autosomal co-dominant inheritance was purified by preparative Immobiline isoelectric focusing. Sequence analysis after cleavage with lysyl endopeptidase and CNBr, followed by high-performance liquid chromatography revealed a single substitution of lysine at position 110, instead of the usual glutamic acid. This mutant apolipoprotein A-I has much the same potential as to activate lecithin-cholesterol acyltransferase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107878     DOI: 10.1016/0005-2760(90)90292-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity.

Authors:  Nahuel A Ramella; Guillermo R Schinella; Sergio T Ferreira; Eduardo D Prieto; María E Vela; José Luis Ríos; M Alejandra Tricerri; Omar J Rimoldi
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

Review 2.  Structural Insights into High Density Lipoprotein: Old Models and New Facts.

Authors:  Valentin Gogonea
Journal:  Front Pharmacol       Date:  2016-01-12       Impact factor: 5.810

3.  Age-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans.

Authors:  Mehran Rahimi; Manlio Vinciguerra; Mojtaba Daghighi; Behiye Özcan; Vishtaseb Akbarkhanzadeh; Fareeba Sheedfar; Marzyeh Amini; Tommaso Mazza; Valerio Pazienza; Mahdi M Motazacker; Morteza Mahmoudi; Felix W M De Rooij; Eric Sijbrands; Maikel P Peppelenbosch; Farhad Rezaee
Journal:  Oncotarget       Date:  2015-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.